Open Letter: Request to Relay a Collaboration Proposal in Cancer Treatment Innovation

I am writing to share my perspective on a critical issue in cancer therapy—specifically, the challenge of effectively eliminating Cancer Stem Cells (CSCs) to prevent recurrence and metastasis. A recent discussion in the article The Root of Recurrence: Targeting Cancer’s Resilient Core by Justus R. Hope has underscored that conventional treatments like surgery, chemotherapy, and radiation frequently fall short because they do not address CSCs. These cells possess the ability to regenerate tumors even after the primary tumor mass is removed, making them a key driver of cancer relapse.

In my own work, I have developed an innovative Intra-Tumoral Chlorine Dioxide Injection Therapy that rapidly eliminates solid tumors with no side effects. This approach has shown significant promise in swiftly reducing tumor burden. However, I recognize that achieving a complete and durable cure requires a dual strategy—one that not only eradicates the visible tumor but also targets the resilient CSCs.

It is evident that combining my intra-tumoral treatment with agents such as Ivermectin—known for its capacity to inhibit key CSC signaling pathways like WNT, Notch, and Hedgehog—could offer a comprehensive, side-effect-free solution. This combination has the potential to overcome the limitations of current cancer therapies by fully eliminating both the tumor mass and its underlying CSCs, thereby preventing relapse and metastasis.

I earnestly hope that my ideas for this synergistic approach will be communicated to experts and thought leaders in the field of oncology. I invite anyone who sees the potential in this innovative strategy to kindly relay my proposal to relevant parties, including researchers involved in CSC-targeted treatments.

Thank you for your attention and support as we collectively strive to transform cancer therapy and improve patient outcomes.